Healthcare provider profile · identity verified

Katrina M Timson, MD

Family Practice · NEWARK, OH · NPI 1144228131

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	883	268
Albuterol Sulfate Hfa	Albuterol Sulfate	357	96
Omeprazole	Omeprazole	327	100
Lisinopril	Lisinopril	311	99
Metformin Hcl	Metformin Hcl	266	87
Levothyroxine Sodium	Levothyroxine Sodium	261	70
Hydrochlorothiazide	Hydrochlorothiazide	225	69
Metoprolol Succinate	Metoprolol Succinate	213	70
Amlodipine Besylate	Amlodipine Besylate	212	75
Gabapentin	Gabapentin	187	63
Famotidine	Famotidine	165	49
Losartan Potassium	Losartan Potassium	163	50
Potassium Chloride	Potassium Chloride	151	43
Furosemide	Furosemide	136	48
Fluticasone Propionate	Fluticasone Propionate	127	39
Enalapril Maleate	Enalapril Maleate	125	37
Rosuvastatin Calcium	Rosuvastatin Calcium	121	35
Alendronate Sodium	Alendronate Sodium	119	33
Pantoprazole Sodium	Pantoprazole Sodium	118	37
Glimepiride	Glimepiride	116	37
Trazodone Hcl	Trazodone Hcl	113	42
Meloxicam	Meloxicam	105	28
Metoprolol Tartrate	Metoprolol Tartrate	102	33
Pravastatin Sodium	Pravastatin Sodium	100	27
Pioglitazone Hcl	Pioglitazone Hcl	94	35
Simvastatin	Simvastatin	94	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	82	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	81	27
Allopurinol	Allopurinol	80	21
Eliquis	Apixaban	75	22
Atenolol	Atenolol	72	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	66	20
Carvedilol	Carvedilol	64	25
Breo Ellipta	Fluticasone/Vilanterol	63	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	60	20
Citalopram Hbr	Citalopram Hydrobromide	59	23
Montelukast Sodium	Montelukast Sodium	59	16
Paroxetine Hcl	Paroxetine Hcl	57	20
Naproxen	Naproxen	55	22
Ozempic	Semaglutide	52	14
Clopidogrel	Clopidogrel Bisulfate	51	20
Glipizide	Glipizide	50	18
Ondansetron Hcl	Ondansetron Hcl	48	17
Sertraline Hcl	Sertraline Hcl	48	21
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	48	12
Hydroxyzine Hcl	Hydroxyzine Hcl	47	12
Meclizine Hcl	Meclizine Hcl	47	15
Duloxetine Hcl	Duloxetine Hcl	46	18
Methocarbamol	Methocarbamol	46	18
Warfarin Sodium	Warfarin Sodium	45	11
Diclofenac Sodium	Diclofenac Sodium	44	16
Spironolactone	Spironolactone	43	15
Januvia	Sitagliptin Phosphate	42	12
Lovastatin	Lovastatin	42	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	suppressed
Ibuprofen	Ibuprofen	41	12
Tizanidine Hcl	Tizanidine Hcl	41	11
Amitriptyline Hcl	Amitriptyline Hcl	37	14
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	36	14
Topiramate	Topiramate	36	suppressed
Tramadol Hcl	Tramadol Hcl	36	suppressed
Jardiance	Empagliflozin	35	13
Oxybutynin Chloride Er	Oxybutynin Chloride	35	suppressed
Methadone Hcl	Methadone Hcl	34	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	33	suppressed
Celecoxib	Celecoxib	33	15
Prednisone	Prednisone	33	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	12
Primidone	Primidone	32	suppressed
Mirtazapine	Mirtazapine	31	suppressed
Symbicort	Budesonide/Formoterol Fumarate	31	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	28	suppressed
Baclofen	Baclofen	27	12
Klor-Con M20	Potassium Chloride	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Imipramine Hcl	Imipramine Hcl	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	suppressed
Glipizide Er	Glipizide	25	suppressed
Spiriva Handihaler	Tiotropium Bromide	25	suppressed
Verapamil Er	Verapamil Hcl	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	23	11
Promethazine Hcl	Promethazine Hcl	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Valsartan	Valsartan	22	suppressed
Bumetanide	Bumetanide	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Ammonium Lactate	Ammonium Lactate	18	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	18	suppressed
Nitroglycerin	Nitroglycerin	18	12
Nabumetone	Nabumetone	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	16	suppressed
Metronidazole	Metronidazole	16	suppressed
Nystatin	Nystatin	16	11
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Verapamil Hcl	Verapamil Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Sulindac	Sulindac	15	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Azithromycin	Azithromycin	13	12
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Torsemide	Torsemide	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Admelog Solostar	Insulin Lispro	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Epinephrine	Epinephrine	12	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Ramipril	Ramipril	12	suppressed
Risperidone	Risperidone	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Tegretol	Carbamazepine	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error